Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

BioNTech shares fell 1.2% in premarket trading after BMO downgraded the stock and cut its price target from $128 to $105, citing declining vaccine demand and the termination of a cancer vaccine trial.

08/09/2026 07:01
Complaint Report
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
i
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,